Journals / Cukurova Medical Journal / 2017 / Cilt: 42 - Sayı: 2

Neuropsychiatric evaluation in HIV positive patients: a preliminary study

HIV pozitif hastaların nöropsikiyatrik açıdan değerlendirilmesi: bir ön çalışma

Pages
292–298
Publication Date
2017-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Cognitive impairment and depression is highly prevalent in HIV (+) patients and have negative effects on treatment adherence, psychosocial functioning and quality of life, so these disorders should be examined in regular psychiatric interviews and be treated regardless infection and its treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to assess neuropsychiatric symptoms of HIV infected patients and determine related socio-demographic and clinical features.Material and Methods: A total of 10 HIV (+) outpatients who have been followed in Department of Infectious Diseases and Clinical Microbiology, Cukurova University Medical School were included in the study.
📊
Key Findings & Data:To evaluate cognitive functions, a neuropsychological test battery consisted of 8 tests were administered.
💡
Conclusion & Impact:Conclusion: Cognitive impairment and depression is highly prevalent in HIV (+) patients and have negative effects on treatment adherence, psychosocial functioning and quality of life, so these disorders should be examined in regular psychiatric interviews and be treated regardless infection and its treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:HIV · nöropsikoloji · depresyon

Abstract

Purpose: The aim of this study was to assess neuropsychiatric symptoms of HIV infected patients and determine related socio-demographic and clinical features.Material and Methods: A total of 10 HIV (+) outpatients who have been followed in Department of Infectious Diseases and Clinical Microbiology, Cukurova University Medical School were included in the study. To evaluate cognitive functions, a neuropsychological test battery consisted of 8 tests were administered. All patients completed Symptom Check List (SCL-90) to determine psychological symptoms and Hamilton Depression Rating Scale (HAM-D) were used to evaluate the severity of depression.Results: The sample included 10 patients (4 females, 6 males). All patients had low or mid socioeconomic status, one half were married and seven patients had high or more level education. Executive functions and memory were impaired secondary to attentional narrowing in all HIV infected patients. Four patients were not diagnosed as depression (HAM-D<7) and other had mild to moderate depression. Only one patient was using an antidepressant medication. Others were neither referred for a psychiatric assessment, nor took a psychiatric treatment. Depression, obsessive-compulsive symptoms, somatization and interpersonal sensitivity subscales found to be high as were measured by SCL-90. Conclusion: Cognitive impairment and depression is highly prevalent in HIV (+) patients and have negative effects on treatment adherence, psychosocial functioning and quality of life, so these disorders should be examined in regular psychiatric interviews and be treated regardless infection and its treatment.

Özet

Amaç: Bu çalışmada HIV (+) bireylerde nöropsikiyatrik belirtilerin ve ilişkili sosyodemografik ve klinik bulguların değerlendirilmesi amaçlanmıştır.

🔖

Cite This Article

KESKİN, N., EVLİCE, A. T., ÇAKMAK, S., TAMAM, L., KÖMÜR, S. (2017). Neuropsychiatric evaluation in HIV positive patients: a preliminary study. Cukurova Medical Journal, Cilt: 42 - Sayı: 2, 292–298. https://ajindex.com/articles/56665

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Sadock BJ, Sadock VA. Nöropsikiyatrik açıdan HIV/AİDS. In Kaplan ve Sadock Klinik Psikiyatri El Kitabı, 4. Baskı (Çeviri Ed A Bozkurt):67-77. Ankara, Güneş Tıp Kitapevi, 2009
  2. WHO. AIDS Epidemic Update November 2009. Geneva, World Health Organization, 2009
  3. TC Sağlık Bakanlığı. Türkiye’de HIV/AIDS Vakalarının Dağılımı (Aralık 2012). Ankara, Sağlık Bakanlığı, 2012
  4. Bakım B, Özçelik B, Karamustafalıoğlu KO. HIV ile enfekte hastalarda gözlenen psikiyatrik bozukluklar. Düşünen Adam. 2005;18:149-56
  5. Gongvatana A, Woods SP, Taylor MJ, Vigil O, Grant I. Semantic clustering inefficiency in HIV associated dementia. J Neuropsychiatry Clin Neurosci. 2007;19:36–42
  6. Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10:44
  7. Robertson K, Liner J, Heaton R. Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev. 2009;19:232-49
  8. Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ et al. Neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci. 1992l;4:386-94
  9. Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize Mini Mental Testin Türk toplumunda hafif demans tanısında geçerlilik ve güvenirliği. Turk Psikiyatri Derg. 2002;13:273-81
  10. MacLeod CM. Half a centry of research on the Stroop effect: n integrative review. Psychol Bull. 1991;109:162-203
  11. Karakaş S, Kafadar H. Bilişsel süreçlerin değerlendirilmesinde nöropsikolojik testler: bellek ve dikkatin ölçülmesi. Şizofreni Dizisi. 1999;4:132-52
  12. Cangöz B, Karakoç E, Selekler K. Saat çizme testinin 50 yaş ve üzeri Türk ve yaşlı örneklemdeki norm belirleme ve geçerlik-güvenirlik çalışmaları. Turkish Journal of Geriatrics. 2006;9:136-42
  13. Can SS, Özelkızıl ET, Varlı M, Turan E, Atlı T. Demans hastalarında üç farklı Saat Çizme Testinin Türkçe uyarlamalarının psikometrik özellikleri. Noro Psikiyatr Ars. 2010;47:91-5
  14. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62
  15. Akdemir A, Örsel S, Dağ İ, Türkçapar H, İşcan N, Özbay H. Hamilton depresyon derecelendirme ölçeği (HDDO)’nin geçerliliği, güvenilirliği ve klinikte kullanımı. Psikiyatri Psikoloji Psikofarmakoloji Dergisi. 1996;4:251-59
  16. Derogatis LR. SCL-90-R, Administration, Scoring and Procedure Manual for the Revised Versi